Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease
- PMID: 30865912
- DOI: 10.25270/jic/18.00331
Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease
Abstract
Background: The incidence of contrast-induced acute kidney injury (CI-AKI) is particularly high in patients with severe chronic kidney disease (CKD). Novel contrast-sparing strategies are warranted to guarantee the benefit of revascularization in this challenging and growing patient population. We aimed to evaluate the feasibility of an ultra-low contrast volume percutaneous coronary intervention (ULC-PCI) protocol in patients with severe CKD.
Methods: The ULC-PCI protocol is based on the prespecification of the maximum contrast volume to be administered, extensive intravascular ultrasound (IVUS) and/or dextran-based optical coherence tomography (OCT) guidance, and use of diluted contrast media. We created a retrospective registry to compare the outcomes of the ULC-PCI protocol vs conventional angiography-based PCI in patients with estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m², applying no angiographic or procedural restriction criteria.
Results: We included 111 patients (ULC-PCI group, n = 8; conventional group, n = 103). Baseline clinical and angiographic characteristics were similar between groups. Contrast volume (8.8 mL [interquartile range, 1.3-18.5] vs 90 mL [interquartile range, 58-140 mL]; P<.001) was markedly lower in the ULC-PCI group. Technical success was achieved in all ULC-PCI procedures; in 7 of the 8 cases (88%), the ULC-PCI protocol was also successful (contrast-volume-to-eGFR ratio <1). The incidence of CI-AKI was 0% vs 15.5% in the ULC-PCI and conventional groups, respectively (P=.28). Procedures in the ULC-PCI group included the use of rotational atherectomy, two-stent bifurcation PCI, and mechanically supported chronic total occlusion PCI.
Conclusions: An ULC-PCI protocol in patients with advanced CKD is feasible, appears to be safe, and has the potential to decrease the incidence of CI-AKI, compared with angiographic guidance alone.
Keywords: CI-AKI; CIN; contrast-induced acute kidney injury; contrast-induced nephropathy; percutaneous coronary intervention.
Similar articles
-
Ultra-low CONtraSt PCI vs conVEntional PCI in patients of ACS with increased risk of CI-AKI (CONSaVE-AKI).Indian Heart J. 2022 Sep-Oct;74(5):363-368. doi: 10.1016/j.ihj.2022.08.004. Epub 2022 Aug 22. Indian Heart J. 2022. PMID: 36007555 Free PMC article. Clinical Trial.
-
Feasibility and safety of minimal-contrast IVUS-guided rotational atherectomy for complex calcified coronary artery disease.Clin Res Cardiol. 2021 Oct;110(10):1668-1679. doi: 10.1007/s00392-021-01906-y. Epub 2021 Jul 13. Clin Res Cardiol. 2021. PMID: 34255133
-
Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.JACC Cardiovasc Interv. 2018 Aug 27;11(16):1601-1610. doi: 10.1016/j.jcin.2018.04.007. JACC Cardiovasc Interv. 2018. PMID: 30139467 Clinical Trial.
-
Procedural Strategies to Reduce the Incidence of Contrast-Induced Acute Kidney Injury During Percutaneous Coronary Intervention.JACC Cardiovasc Interv. 2019 Oct 14;12(19):1877-1888. doi: 10.1016/j.jcin.2019.04.055. Epub 2019 Sep 11. JACC Cardiovasc Interv. 2019. PMID: 31521648 Review.
-
Trimetazidine as an adjunct to standard hydration reduces the incidence of contrast-induced acute kidney injury in patients with renal insufficiency undergoing coronary angiography or percutaneous cardiac intervention: a systematic review and meta-analysis.BMC Nephrol. 2024 Dec 23;25(1):471. doi: 10.1186/s12882-024-03872-9. BMC Nephrol. 2024. PMID: 39716106 Free PMC article.
Cited by
-
Safety and Biodistribution of an Autologous Bone Marrow-Derived Mononuclear Cell Infusion into Renal Arteries in Patients with Focal Segmental Glomerulosclerosis: A Phase 1 Study.Stem Cells Int. 2024 Jul 9;2024:2385568. doi: 10.1155/2024/2385568. eCollection 2024. Stem Cells Int. 2024. PMID: 39015674 Free PMC article.
-
When to use intravascular ultrasound or optical coherence tomography during percutaneous coronary intervention?Cardiovasc Diagn Ther. 2020 Oct;10(5):1429-1444. doi: 10.21037/cdt-20-206. Cardiovasc Diagn Ther. 2020. PMID: 33224766 Free PMC article. Review.
-
Safety of ultra-low contrast coronary angiography in patients with acute kidney injury.Clin Cardiol. 2024 May;47(5):e24282. doi: 10.1002/clc.24282. Clin Cardiol. 2024. PMID: 38801137 Free PMC article.
-
Procedural outcomes of chronic total occlusion percutaneous coronary interventions in patients with acute kidney injury.Cardiol J. 2024;31(1):84-94. doi: 10.5603/CJ.a2022.0121. Epub 2023 Jan 2. Cardiol J. 2024. PMID: 36588312 Free PMC article.
-
Coronary Intervention Outcomes in Patients with Liver Cirrhosis.Curr Cardiol Rep. 2025 Jan 4;27(1):2. doi: 10.1007/s11886-024-02163-x. Curr Cardiol Rep. 2025. PMID: 39754700 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous